Related Experiment Video
Updated: Jan 20, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
IDH1-mutated relapsed or refractory AML: current challenges and future prospects.
Juan Eduardo Megías-Vericat1, Octavio Ballesta-López1, Eva Barragán2,3
1Servicio de Farmacia, Área del Medicamento, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Targeted therapies like isocitrate dehydrogenase 1 (IDH1) inhibitors offer new hope for relapsed or refractory acute myeloid leukemia (R/R AML) patients. These agents show promising outcomes and manageable safety profiles in clinical studies.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Relapsed or refractory acute myeloid leukemia (R/R AML) presents a significant clinical challenge with poor prognoses.
- Isocitrate dehydrogenase 1 (IDH1) mutations occur in 7-14% of AML patients, representing a targetable pathway.
Purpose of the Study:
- To systematically review clinical outcomes and safety of IDH1 inhibitors and other agents in adult IDH1-mutated R/R AML.
- To evaluate the efficacy of targeted therapies in a difficult-to-treat AML population.
Main Methods:
- Systematic literature review of clinical trials and studies involving IDH1 inhibitors in R/R AML.
- Analysis of reported complete remission (CR), overall response (OR), and overall survival (OS) data.
Main Results:
- Ivosidenib monotherapy demonstrated a 24% CR, 42% OR, and 9-month median OS in R/R AML.
- Other IDH1 inhibitors (IDH305, FT-2102) also showed promising results.
- IDH1 inhibitors were generally well-tolerated, with manageable toxicities like IDH-differentiation syndrome.
Conclusions:
- IDH1 inhibitors represent a promising targeted approach for IDH1-mutated R/R AML.
- Ongoing trials with other agents (venetoclax, PARP inhibitors, etc.) will further define the role of IDH1-targeted therapies in AML treatment strategies.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms
Point and Frameshift Mutations

